Cuicui Liu

Nanjing, 210032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Genomic Determinants and an Exploratory Prognostic Model for Immunotherapy Outcomes in Recurrent or Metastatic Cervical Cancer.

Genomic Determinants and an Exploratory Prognostic Model for Immunotherapy Outcomes in Recurrent or Metastatic Cervical Cancer.

Journal: The oncologist
Published: January 20, 2026

Individualized management strategies for advanced non-small cell lung cancer with EGFR exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report.

Individualized management strategies for advanced non-small cell lung cancer with EGFR exon 19 deletion and L861Q compound mutations based on circulating tumor DNA monitoring: A case report.

Journal: Oncology letters
Published: June 20, 2025

Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.

Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers.

Journal: Translational lung cancer research
Published: May 08, 2025

Anlotinib treatment for rapidly progressing pediatric embryonal rhabdomyosarcoma in the maxillary gingiva: a case report.

Anlotinib treatment for rapidly progressing pediatric embryonal rhabdomyosarcoma in the maxillary gingiva: a case report.

Journal: Diagnostic pathology
Published: July 03, 2024

Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL.

Association between low incidence of TP53 mutations and reduced early relapse rates in Uygur DLBCL.

Journal: Annals of hematology
Published: March 14, 2024

The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.

The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.

Journal: Gynecologic oncology
Published: January 30, 2023

Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.

Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.

Journal: Cancer science
Published: December 09, 2022

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors.

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors.

Journal: Frontiers in immunology
Published: July 26, 2022

Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes.

Rare mutation-dominant compound EGFR-positive NSCLC is associated with enriched kinase domain-resided variants of uncertain significance and poor clinical outcomes.

Journal: BMC medicine
Published: June 14, 2022

Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.

Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 04, 2022

Anticancer activity of binary toxins from Lysinibacillus sphaericus IAB872 against human lung cancer cell line A549.

Anticancer activity of binary toxins from Lysinibacillus sphaericus IAB872 against human lung cancer cell line A549.

Journal: Natural product communications
Published: March 26, 2014
Showing 1-11 of 11

Last Updated: 09/26/2026